Oruka Therapeutics (ORKA) Amortizatization of Intangibles (2015 - 2026)
Oruka Therapeutics' (ORKA) quarterly Amortizatization of Intangibles came in at $446000.0 in Q1 2026, down 75.18% year-on-year from $1.8 million in Q1 2025, and down 32.73% quarter-over-quarter from $663000.0 in Q4 2025.
Oruka Therapeutics (ORKA) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends
Oruka Therapeutics' Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $446000.0 for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 75.18% year-over-year to $446000.0 in Q1 2026; TTM through Mar 2026 was $3.7 million, a 103.23% increase from a year earlier, with the FY2025 full-year figure at $5.0 million, up 122.85% from the prior year.
- Amortizatization of Intangibles eased to $446000.0 in Q1 2026 per ORKA's latest filing, from $663000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.8 million in Q1 2025 and bottomed at $446000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Oruka Therapeutics | 949.58 Mn | 118.43 Mn | - | 446,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 446,000.00 |
| Mar 31, 2026 | 446,000.00 |
| Dec 31, 2025 | 663,000.00 |
| Dec 31, 2025 | 663,000.00 |
| Sep 30, 2025 | 1.04 Mn |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Mar 31, 2018 | -2,000.00 |
| Mar 31, 2018 | -2,000.00 |
| Dec 31, 2017 | 438,000.00 |
| Dec 31, 2017 | 438,000.00 |
| Sep 30, 2017 | -288,000.00 |
| Sep 30, 2017 | -288,000.00 |
| Jun 30, 2017 | 89,000.00 |
| Jun 30, 2017 | 89,000.00 |
| Mar 31, 2017 | 90,000.00 |
| Mar 31, 2017 | 90,000.00 |